Advertisement

Index by author

June 01, 2013; Volume 345,Issue 3

  1. Takahashi, Teisuke

    1. Effects of a New SGLT2 Inhibitor, Luseogliflozin, on Diabetic Nephropathy in T2DN Rats
      Naoki Kojima, Jan M. Williams, Teisuke Takahashi, Noriyuki Miyata and Richard J. Roman
      Journal of Pharmacology and Experimental Therapeutics June 2013, 345 (3) 464-472; DOI: https://doi.org/10.1124/jpet.113.203869

  2. Talan, Mark I.

    1. Chronic Administration of Small Nonerythropoietic Peptide Sequence of Erythropoietin Effectively Ameliorates the Progression of Postmyocardial Infarction–Dilated Cardiomyopathy
      Ismayil Ahmet, Hyun-Jin Tae, Michael Brines, Anthony Cerami, Edward G. Lakatta and Mark I. Talan
      Journal of Pharmacology and Experimental Therapeutics June 2013, 345 (3) 446-456; DOI: https://doi.org/10.1124/jpet.113.202945

  3. Tanaka, Yuji

    1. Ezetimibe Increases Hepatic Iron Levels in Mice Fed a High-Fat Diet
      Yoshizumi Kishino, Yuji Tanaka, Takanori Ikeda, Kazuo Yamamoto, Hiroshi Ogawa, Yoshinori Iwatani and Toshinori Kamisako
      Journal of Pharmacology and Experimental Therapeutics June 2013, 345 (3) 483-491; DOI: https://doi.org/10.1124/jpet.113.203448

  4. Thomsen, William J.

    1. Parathyroid Hormone (PTH) and PTH-Related Peptide Domains Contributing to Activation of Different PTH Receptor–Mediated Signaling Pathways
      Meghan E. Cupp, Surendra K. Nayak, Amina S. Adem and William J. Thomsen
      Journal of Pharmacology and Experimental Therapeutics June 2013, 345 (3) 404-418; DOI: https://doi.org/10.1124/jpet.112.199752

  5. Tibbs, Gareth R.

    1. HCN1 Channels as Targets for Anesthetic and Nonanesthetic Propofol Analogs in the Amelioration of Mechanical and Thermal Hyperalgesia in a Mouse Model of Neuropathic Pain
      Gareth R. Tibbs, Thomas J. Rowley, R. Lea Sanford, Karl F. Herold, Alex Proekt, Hugh C. Hemmings, Olaf S. Andersen, Peter A. Goldstein and Pamela D. Flood
      Journal of Pharmacology and Experimental Therapeutics June 2013, 345 (3) 363-373; DOI: https://doi.org/10.1124/jpet.113.203620

  6. Ulu, Nadir

    1. Epidermal Growth Factor Receptor Inhibitor PKI-166 Governs Cardiovascular Protection without Beneficial Effects on the Kidney in Hypertensive 5/6 Nephrectomized Rats
      Nadir Ulu, Gemma M. Mulder, Peter Vavrinec, Sjoerd W. Landheer, Basak Duman-Dalkilic, Hakan Gurdal, Maaike Goris, Marry Duin, Richard P. E. van Dokkum, Hendrik Buikema, Harry van Goor and Robert H. Henning
      Journal of Pharmacology and Experimental Therapeutics June 2013, 345 (3) 393-403; DOI: https://doi.org/10.1124/jpet.113.203497

  7. Van Dokkum, Richard P. E.

    1. Epidermal Growth Factor Receptor Inhibitor PKI-166 Governs Cardiovascular Protection without Beneficial Effects on the Kidney in Hypertensive 5/6 Nephrectomized Rats
      Nadir Ulu, Gemma M. Mulder, Peter Vavrinec, Sjoerd W. Landheer, Basak Duman-Dalkilic, Hakan Gurdal, Maaike Goris, Marry Duin, Richard P. E. van Dokkum, Hendrik Buikema, Harry van Goor and Robert H. Henning
      Journal of Pharmacology and Experimental Therapeutics June 2013, 345 (3) 393-403; DOI: https://doi.org/10.1124/jpet.113.203497

  8. Van Goor, Harry

    1. Epidermal Growth Factor Receptor Inhibitor PKI-166 Governs Cardiovascular Protection without Beneficial Effects on the Kidney in Hypertensive 5/6 Nephrectomized Rats
      Nadir Ulu, Gemma M. Mulder, Peter Vavrinec, Sjoerd W. Landheer, Basak Duman-Dalkilic, Hakan Gurdal, Maaike Goris, Marry Duin, Richard P. E. van Dokkum, Hendrik Buikema, Harry van Goor and Robert H. Henning
      Journal of Pharmacology and Experimental Therapeutics June 2013, 345 (3) 393-403; DOI: https://doi.org/10.1124/jpet.113.203497

  9. Varney, Mark A.

    1. Pharmacodynamic Effects of a d-Amino Acid Oxidase Inhibitor Indicate a Spinal Site of Action in Rat Models of Neuropathic Pain
      Seth C. Hopkins, Fei-Yue Zhao, Carrie A. Bowen, Xin Fang, Haifeng Wei, Michele L. R. Heffernan, Kerry L. Spear, David C. Spanswick, Mark A. Varney and Thomas H. Large
      Journal of Pharmacology and Experimental Therapeutics June 2013, 345 (3) 502-511; DOI: https://doi.org/10.1124/jpet.113.204016

  10. Vavrinec, Peter

    1. Epidermal Growth Factor Receptor Inhibitor PKI-166 Governs Cardiovascular Protection without Beneficial Effects on the Kidney in Hypertensive 5/6 Nephrectomized Rats
      Nadir Ulu, Gemma M. Mulder, Peter Vavrinec, Sjoerd W. Landheer, Basak Duman-Dalkilic, Hakan Gurdal, Maaike Goris, Marry Duin, Richard P. E. van Dokkum, Hendrik Buikema, Harry van Goor and Robert H. Henning
      Journal of Pharmacology and Experimental Therapeutics June 2013, 345 (3) 393-403; DOI: https://doi.org/10.1124/jpet.113.203497
« Previous (Pages : 7 8 9 10 11 12 ... 12) Next »
Back to top

In this issue

Advertisement